APO Research
Talk to an analyst

APO RESEARCH · REPORT

Keratosis Pilaris Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Keratosis Pilaris Treatment Market Analysis and Forecast 2026-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchKeratosis Pilaris Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Keratosis Pilaris Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Keratosis Pilaris Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Keratosis Pilaris Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Keratosis Pilaris Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Keratosis Pilaris Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Keratosis Pilaris Treatment include AmLactin (Novartis), CeraVe (L'Oréal), DERMAdoctor, Eucerin (Beiersdorf AG), Excipial (Galderma), First Aid Beauty (P&G), Neutrogena (Johnson & Johnson), Nip + Fab and Paula’s Choice, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Keratosis Pilaris Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Keratosis Pilaris Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Keratosis Pilaris Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Keratosis Pilaris Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Keratosis Pilaris Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Keratosis Pilaris Treatment revenue, projected growth trends, production technology, application and end-user industry.

Keratosis Pilaris Treatment Segment by Company

AmLactin (Novartis)

CeraVe (L'Oréal)

DERMAdoctor

Eucerin (Beiersdorf AG)

Excipial (Galderma)

First Aid Beauty (P&G)

Neutrogena (Johnson & Johnson)

Nip + Fab

Paula’s Choice

SLMD Skincare

Touch Skin Care

Keratosis Pilaris Treatment Segment by Type

Body Scrub

Lotion

Body Wash & Shower Gel

Other

Keratosis Pilaris Treatment Segment by Application

For Body

For Facial Skin

Keratosis Pilaris Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Keratosis Pilaris Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Keratosis Pilaris Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Keratosis Pilaris Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Keratosis Pilaris Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Keratosis Pilaris Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Keratosis Pilaris Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Keratosis Pilaris Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Body Scrub Major Player Table 3. Lotion Major Player Table 4. Body Wash & Shower Gel Major Player Table 5. Other Major Player Table 6. Global Keratosis Pilaris Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Body Major Player Table 8. For Facial Skin Major Player Table 9. Keratosis Pilaris Treatment Industry Trends Table 10. Keratosis Pilaris Treatment Industry Drivers Table 11. Keratosis Pilaris Treatment Industry Opportunities and Challenges Table 12. Keratosis Pilaris Treatment Industry Restraints Table 13. Global Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Keratosis Pilaris Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Keratosis Pilaris Treatment Market Share by Region (2021-2026) Table 16. Global Keratosis Pilaris Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Keratosis Pilaris Treatment Market Share by Region (2027-2032) Table 18. Global Keratosis Pilaris Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Keratosis Pilaris Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Keratosis Pilaris Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Keratosis Pilaris Treatment Key Players Headquarters & Area Served Table 22. Global Keratosis Pilaris Treatment Players, Product Type & Application Table 23. Global Keratosis Pilaris Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Keratosis Pilaris Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Keratosis Pilaris Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Keratosis Pilaris Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Keratosis Pilaris Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Keratosis Pilaris Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2027-2032) Table 36. AmLactin (Novartis) Company Information Table 37. AmLactin (Novartis) Business Overview Table 38. AmLactin (Novartis) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio Table 40. AmLactin (Novartis) Recent Development Table 41. CeraVe (L'Oréal) Company Information Table 42. CeraVe (L'Oréal) Business Overview Table 43. CeraVe (L'Oréal) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio Table 45. CeraVe (L'Oréal) Recent Development Table 46. DERMAdoctor Company Information Table 47. DERMAdoctor Business Overview Table 48. DERMAdoctor Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. DERMAdoctor Keratosis Pilaris Treatment Product Portfolio Table 50. DERMAdoctor Recent Development Table 51. Eucerin (Beiersdorf AG) Company Information Table 52. Eucerin (Beiersdorf AG) Business Overview Table 53. Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio Table 55. Eucerin (Beiersdorf AG) Recent Development Table 56. Excipial (Galderma) Company Information Table 57. Excipial (Galderma) Business Overview Table 58. Excipial (Galderma) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio Table 60. Excipial (Galderma) Recent Development Table 61. First Aid Beauty (P&G) Company Information Table 62. First Aid Beauty (P&G) Business Overview Table 63. First Aid Beauty (P&G) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio Table 65. First Aid Beauty (P&G) Recent Development Table 66. Neutrogena (Johnson & Johnson) Company Information Table 67. Neutrogena (Johnson & Johnson) Business Overview Table 68. Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio Table 70. Neutrogena (Johnson & Johnson) Recent Development Table 71. Nip + Fab Company Information Table 72. Nip + Fab Business Overview Table 73. Nip + Fab Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Nip + Fab Keratosis Pilaris Treatment Product Portfolio Table 75. Nip + Fab Recent Development Table 76. Paula’s Choice Company Information Table 77. Paula’s Choice Business Overview Table 78. Paula’s Choice Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Paula’s Choice Keratosis Pilaris Treatment Product Portfolio Table 80. Paula’s Choice Recent Development Table 81. SLMD Skincare Company Information Table 82. SLMD Skincare Business Overview Table 83. SLMD Skincare Keratosis Pilaris Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. SLMD Skincare Keratosis Pilaris Treatment Product Portfolio Table 85. SLMD Skincare Recent Development Table 86. Touch Skin Care Company Information Table 87. Touch Skin Care Business Overview Table 88. Touch Skin Care Keratosis Pilaris Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Touch Skin Care Keratosis Pilaris Treatment Product Portfolio Table 90. Touch Skin Care Recent Development Table 91. North America Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Keratosis Pilaris Treatment Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Keratosis Pilaris Treatment Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Keratosis Pilaris Treatment Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Keratosis Pilaris Treatment Revenue by Country (US$ Million) & (2027-2032) Table 105. China Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 106. China Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 107. China Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 108. China Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Keratosis Pilaris Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Keratosis Pilaris Treatment Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Keratosis Pilaris Treatment Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Keratosis Pilaris Treatment Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Keratosis Pilaris Treatment Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Keratosis Pilaris Treatment Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Keratosis Pilaris Treatment Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Keratosis Pilaris Treatment Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Keratosis Pilaris Treatment Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Keratosis Pilaris Treatment Image Figure 2. Global Keratosis Pilaris Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Keratosis Pilaris Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Body Scrub Image Figure 5. Lotion Image Figure 6. Body Wash & Shower Gel Image Figure 7. Other Image Figure 8. Global Keratosis Pilaris Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Keratosis Pilaris Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Body Image Figure 11. For Facial Skin Image Figure 12. Global Keratosis Pilaris Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Keratosis Pilaris Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Keratosis Pilaris Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Keratosis Pilaris Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Keratosis Pilaris Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Keratosis Pilaris Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Keratosis Pilaris Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Keratosis Pilaris Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Keratosis Pilaris Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Keratosis Pilaris Treatment Revenue Share by Type (2021-2032) Figure 25. North America Keratosis Pilaris Treatment Revenue Share by Application (2021-2032) Figure 26. North America Keratosis Pilaris Treatment Revenue Share by Country (2021-2032) Figure 27. United States Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Keratosis Pilaris Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Keratosis Pilaris Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Keratosis Pilaris Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Keratosis Pilaris Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Keratosis Pilaris Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Keratosis Pilaris Treatment Revenue Share by Type (2021-2032) Figure 44. China Keratosis Pilaris Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Keratosis Pilaris Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Keratosis Pilaris Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Keratosis Pilaris Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Keratosis Pilaris Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Keratosis Pilaris Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Keratosis Pilaris Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Keratosis Pilaris Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Keratosis Pilaris Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Keratosis Pilaris Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Body Scrub
  • Lotion
  • Body Wash & Shower Gel
  • Other
Applications
  • For Body
  • For Facial Skin
Companies covered
  • AmLactin (Novartis)
  • CeraVe (L'Oréal)
  • DERMAdoctor
  • Eucerin (Beiersdorf AG)
  • Excipial (Galderma)
  • First Aid Beauty (P&G)
  • Neutrogena (Johnson & Johnson)
  • Nip + Fab
  • Paula’s Choice
  • SLMD Skincare
  • Touch Skin Care

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Keratosis Pilaris Treatment Market by Type
  3. 1.2.1 Global Keratosis Pilaris Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Body Scrub
  5. 1.2.3 Lotion
  6. 1.2.4 Body Wash & Shower Gel
  7. 1.2.5 Other
  8. 1.3 Keratosis Pilaris Treatment Market by Application
  9. 1.3.1 Global Keratosis Pilaris Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Body
  11. 1.3.3 For Facial Skin
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Keratosis Pilaris Treatment Market Dynamics
  1. 2.1 Keratosis Pilaris Treatment Industry Trends
  2. 2.2 Keratosis Pilaris Treatment Industry Drivers
  3. 2.3 Keratosis Pilaris Treatment Industry Opportunities and Challenges
  4. 2.4 Keratosis Pilaris Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Keratosis Pilaris Treatment Market Perspective (2021-2032)
  2. 3.2 Global Keratosis Pilaris Treatment Growth Trends by Region
  3. 3.2.1 Global Keratosis Pilaris Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Keratosis Pilaris Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Keratosis Pilaris Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Keratosis Pilaris Treatment Revenue by Players
  2. 4.1.1 Global Keratosis Pilaris Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Keratosis Pilaris Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Keratosis Pilaris Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Keratosis Pilaris Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Keratosis Pilaris Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Keratosis Pilaris Treatment Players, Product Type & Application
  8. 4.5 Global Keratosis Pilaris Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Keratosis Pilaris Treatment Market CR5 and HHI
  11. 4.6.3 2025 Keratosis Pilaris Treatment Tier 1, Tier 2, and Tier 3
5 Keratosis Pilaris Treatment Market Size by Type
  1. 5.1 Global Keratosis Pilaris Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Keratosis Pilaris Treatment Revenue Market Share by Type (2021-2032)
6 Keratosis Pilaris Treatment Market Size by Application
  1. 6.1 Global Keratosis Pilaris Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Keratosis Pilaris Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AmLactin (Novartis)
  2. 7.1.1 AmLactin (Novartis) Company Information
  3. 7.1.2 AmLactin (Novartis) Business Overview
  4. 7.1.3 AmLactin (Novartis) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio
  6. 7.1.5 AmLactin (Novartis) Recent Developments
  7. 7.2 CeraVe (L'Oréal)
  8. 7.2.1 CeraVe (L'Oréal) Company Information
  9. 7.2.2 CeraVe (L'Oréal) Business Overview
  10. 7.2.3 CeraVe (L'Oréal) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio
  12. 7.2.5 CeraVe (L'Oréal) Recent Developments
  13. 7.3 DERMAdoctor
  14. 7.3.1 DERMAdoctor Company Information
  15. 7.3.2 DERMAdoctor Business Overview
  16. 7.3.3 DERMAdoctor Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DERMAdoctor Keratosis Pilaris Treatment Product Portfolio
  18. 7.3.5 DERMAdoctor Recent Developments
  19. 7.4 Eucerin (Beiersdorf AG)
  20. 7.4.1 Eucerin (Beiersdorf AG) Company Information
  21. 7.4.2 Eucerin (Beiersdorf AG) Business Overview
  22. 7.4.3 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio
  24. 7.4.5 Eucerin (Beiersdorf AG) Recent Developments
  25. 7.5 Excipial (Galderma)
  26. 7.5.1 Excipial (Galderma) Company Information
  27. 7.5.2 Excipial (Galderma) Business Overview
  28. 7.5.3 Excipial (Galderma) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio
  30. 7.5.5 Excipial (Galderma) Recent Developments
  31. 7.6 First Aid Beauty (P&G)
  32. 7.6.1 First Aid Beauty (P&G) Company Information
  33. 7.6.2 First Aid Beauty (P&G) Business Overview
  34. 7.6.3 First Aid Beauty (P&G) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio
  36. 7.6.5 First Aid Beauty (P&G) Recent Developments
  37. 7.7 Neutrogena (Johnson & Johnson)
  38. 7.7.1 Neutrogena (Johnson & Johnson) Company Information
  39. 7.7.2 Neutrogena (Johnson & Johnson) Business Overview
  40. 7.7.3 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio
  42. 7.7.5 Neutrogena (Johnson & Johnson) Recent Developments
  43. 7.8 Nip + Fab
  44. 7.8.1 Nip + Fab Company Information
  45. 7.8.2 Nip + Fab Business Overview
  46. 7.8.3 Nip + Fab Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nip + Fab Keratosis Pilaris Treatment Product Portfolio
  48. 7.8.5 Nip + Fab Recent Developments
  49. 7.9 Paula’s Choice
  50. 7.9.1 Paula’s Choice Company Information
  51. 7.9.2 Paula’s Choice Business Overview
  52. 7.9.3 Paula’s Choice Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Paula’s Choice Keratosis Pilaris Treatment Product Portfolio
  54. 7.9.5 Paula’s Choice Recent Developments
  55. 7.10 SLMD Skincare
  56. 7.10.1 SLMD Skincare Company Information
  57. 7.10.2 SLMD Skincare Business Overview
  58. 7.10.3 SLMD Skincare Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 SLMD Skincare Keratosis Pilaris Treatment Product Portfolio
  60. 7.10.5 SLMD Skincare Recent Developments
  61. 7.11 Touch Skin Care
  62. 7.11.1 Touch Skin Care Company Information
  63. 7.11.2 Touch Skin Care Business Overview
  64. 7.11.3 Touch Skin Care Keratosis Pilaris Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Touch Skin Care Keratosis Pilaris Treatment Product Portfolio
  66. 7.11.5 Touch Skin Care Recent Developments
8 North America
  1. 8.1 North America Keratosis Pilaris Treatment Revenue (2021-2032)
  2. 8.2 North America Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Keratosis Pilaris Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Keratosis Pilaris Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Keratosis Pilaris Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Keratosis Pilaris Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Keratosis Pilaris Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Keratosis Pilaris Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Keratosis Pilaris Treatment Revenue by Country
  11. 8.6.1 North America Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Keratosis Pilaris Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Keratosis Pilaris Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Keratosis Pilaris Treatment Revenue (2021-2032)
  2. 9.2 Europe Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Keratosis Pilaris Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Keratosis Pilaris Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Keratosis Pilaris Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Keratosis Pilaris Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Keratosis Pilaris Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Keratosis Pilaris Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Keratosis Pilaris Treatment Revenue by Country
  11. 9.6.1 Europe Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Keratosis Pilaris Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Keratosis Pilaris Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Keratosis Pilaris Treatment Revenue (2021-2032)
  2. 10.2 China Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Keratosis Pilaris Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Keratosis Pilaris Treatment Revenue by Type (2027-2032)
  5. 10.3 China Keratosis Pilaris Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Keratosis Pilaris Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Keratosis Pilaris Treatment Revenue by Application (2027-2032)
  9. 10.5 China Keratosis Pilaris Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Keratosis Pilaris Treatment Revenue (2021-2032)
  2. 11.2 Asia Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Keratosis Pilaris Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Keratosis Pilaris Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Keratosis Pilaris Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Keratosis Pilaris Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Keratosis Pilaris Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Keratosis Pilaris Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Keratosis Pilaris Treatment Revenue by Country
  11. 11.6.1 Asia Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Keratosis Pilaris Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Keratosis Pilaris Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Keratosis Pilaris Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Keratosis Pilaris Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Keratosis Pilaris Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Keratosis Pilaris Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Keratosis Pilaris Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Keratosis Pilaris Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Keratosis Pilaris Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Keratosis Pilaris Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Keratosis Pilaris Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Keratosis Pilaris Treatment Revenue by Country
  11. 12.6.1 SAMEA Keratosis Pilaris Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Keratosis Pilaris Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Keratosis Pilaris Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst